Trinity Biotech | TRIB - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
EDAP TMS EUR 50.36M 6.01M 2026-03
J&J USD 59.77B 601M 2026-06
Mesa Laboratories USD 105.63M 8.2M 2025-12
OraSure Technologies USD 240.78M 21.13M 2026-03
Plus Therapeutics USD 18.03M 2.86M 2026-03
Roche Holding CHF 35.44B 3.29B 2026-06
Siemens EUR 68.95B 1.04B 2026-03
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Tosoh JPY 835.36B 37.3B 2026-06
Trinity Biotech USD 35.9M 382K 2025-12
Veracyte USD 574.78M 52.6M 2026-06